Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05585034

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +58 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

NCT05253807

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute Fort Myers, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Memorial Healthcare System Pembroke Pines, Florida, United States
View all 36 locations
View Trial Details
Completed

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Affiliated Cancer Hospital of Shandong First Medical University Jinan, China
View Trial Details
Completed

A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

NCT04830826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Chest Hospital，Capital Medical university Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking University People'S Hospital Beijing, Beijing Municipality, China
View all 51 locations
View Trial Details

Related conditions